Original Research
Accepted on 13 Feb 2026
ALKBH5 facilitates acute myeloid leukemia development and immune escape via PD-L1 regulation
in Hematologic Malignancies
Frontiers in Oncology
Type at least 3 characters
2,059 articles
articles
Review
Published on 13 Feb 2026
Acute lymphoblastic leukemia: an update on treatment and Brazilian perspective
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1637924
- 426 views
Original Research
Published on 13 Feb 2026
Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1756247
- 344 views
Case Report
Accepted on 12 Feb 2026
Deceptive Initial Presentation of Systemic DLBCL with CNS Progression Following Oligometabolic PET/CT: Case Report
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 11 Feb 2026
MYC-Positive Follicular Lymphoma Complicated by Refractory Lactate and Clonal Evolution: a case report
in Hematologic Malignancies
Frontiers in Oncology
- 129 views
Original Research
Published on 11 Feb 2026
Multiple myeloma in the real world settings: prognostic significance of 1q21 chromosomal abnormalities - single center experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1765235
- 294 views
Case Report
Published on 10 Feb 2026
A rare case report of relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type, treated with Epcoritamab: results obtained and lesson learned
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1710502
- 451 views
Original Research
Published on 10 Feb 2026
A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1606239
- 589 views
Case Report
Published on 10 Feb 2026
Acute hemiplegia as initial presentation in FIP1L1-PDGFRA-rearranged myeloid neoplasm with eosinophilia: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1628690
- 344 views
Case Report
Accepted on 09 Feb 2026
KMT2A Amplification in Two Adult Patients with B-Cell Acute Lymphoblastic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
- 191 views
Case Report
Accepted on 09 Feb 2026
Safety Analysis of Blinatumomab Consolidation Therapy in Two Cases of Acute B-Cell Lymphoblastic Leukemia in Complete Remission Complicated with Immune Effector Cell-Associated Neurotoxicity Syndrome
in Hematologic Malignancies
Frontiers in Oncology
Review
Accepted on 09 Feb 2026
Risk prediction model for thrombosis in Leukemia patients: A Systematic review
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Published on 06 Feb 2026
Case Report: Targeting the Achilles’ heel of monomorphic epitheliotropic intestinal T-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1710764
- 592 views
Case Report
Accepted on 05 Feb 2026
Unmasking Small-Bowel DLBCL in an Elderly Patient with Simultaneous Multiple Primary Cancers through Anemia: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
Review
Published on 05 Feb 2026
The role of epigenetic modifications in hematological cancers
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1744018
- 550 views
Original Research
Accepted on 04 Feb 2026
A Novel Prognostic Model Integrating Host Vulnerability and Tumor Biology for Elderly Patients with Diffuse Large B-Cell Lymphoma: The BAMAL Score
in Hematologic Malignancies
Frontiers in Oncology
- 118 views
Case Report
Accepted on 04 Feb 2026
Chidamide Combined with Decitabine, Venetoclax, and Low-Dose Cytarabine (LDAC) for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Case Series
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 04 Feb 2026
Low-Grade B-Cell Non-Hodgkin Lymphoma in the Sternocleidomastoid Muscle: A Case Report and Review of Literature
in Hematologic Malignancies
Frontiers in Oncology
Brief Research Report
Accepted on 04 Feb 2026
TLK2 antisense oligonucleotide as a new strategy to target TLK2 in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
- 153 views
Original Research
Published on 04 Feb 2026
Association between the prognostic nutritional index and early mortality of AML patients after allogeneic HSCT: a retrospective cohort analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1754463
- 457 views
Original Research
Published on 04 Feb 2026
Analysis of risk factors for PICC-related venous thrombosis in patients with hematological malignancies and establishment of a nomogram prediction model
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1675200
- 351 views
Original Research
Published on 03 Feb 2026
Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1747186
- 413 views
Original Research
Accepted on 02 Feb 2026
Microtransplantation improves the outcome of older patients with newly diagnosed acute myeloid leukemia: a single-centre study with long-term follow-up
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 02 Feb 2026
Case Report and Literature Review: Golidocitinib as a Potential Treatment for Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
- 131 views